Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel · Delayed Price · Currency is ILS · Price in ILA 10,650
+150 (1.43%)
Aug 10, 2026, 5:27 PM IDT
TLV:TEVA Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 706 | 1,410 | -1,639 | -559 | -2,446 | 417 |
Depreciation & Amortization | 988 | 1,002 | 1,059 | 1,153 | 1,308 | 1,330 |
Loss (Gain) From Sale of Assets | -20 | - | -22 | -41 | 10 | - |
Asset Writedown & Restructuring Costs | 1,697 | 1,028 | 2,555 | 1,078 | 2,447 | 594 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | 104 |
Stock-Based Compensation | 168 | 157 | 123 | 121 | 124 | 119 |
Other Operating Activities | -530 | -582 | -394 | -312 | -1,208 | -65 |
Change in Accounts Receivable | -7 | -173 | 245 | 12 | 334 | -574 |
Change in Inventory | 181 | 152 | 166 | -147 | -163 | 380 |
Change in Accounts Payable | -123 | -15 | 258 | 1,588 | 2,012 | 764 |
Change in Other Net Operating Assets | -1,162 | -1,330 | -1,104 | -1,525 | -828 | -2,271 |
Operating Cash Flow | 1,898 | 1,649 | 1,247 | 1,368 | 1,590 | 798 |
Operating Cash Flow Growth | 36.55% | 32.24% | -8.85% | -13.96% | 99.25% | -34.38% |
Capital Expenditures | -551 | -501 | -498 | -526 | -548 | -562 |
Cash Acquisitions | -696 | - | -15 | - | -7 | - |
Divestitures | 54 | 34 | 43 | 68 | 68 | 311 |
Investment in Securities | 11 | -15 | -31 | -46 | 3 | 125 |
Other Investing Activities | -2 | 5 | 2 | -5 | - | 1 |
Investing Cash Flow | 37 | 737 | 792 | 968 | 656 | 1,523 |
Short-Term Debt Issued | - | - | - | 700 | - | 700 |
Long-Term Debt Issued | - | 2,298 | - | 2,451 | - | 4,974 |
Total Debt Issued | -7 | 2,298 | - | 3,151 | - | 5,674 |
Short-Term Debt Repaid | - | - | - | -700 | - | -700 |
Long-Term Debt Repaid | - | -4,112 | -1,641 | -4,152 | -1,369 | -7,140 |
Total Debt Repaid | -467 | -4,112 | -1,641 | -4,852 | -1,369 | -7,840 |
Net Debt Issued (Repaid) | -474 | -1,814 | -1,641 | -1,701 | -1,369 | -2,166 |
Other Financing Activities | 73 | -337 | -150 | -212 | -118 | -6 |
Financing Cash Flow | -401 | -2,151 | -1,791 | -1,913 | -1,487 | -2,172 |
Foreign Exchange Rate Adjustments | -41 | 21 | -174 | -30 | -123 | -128 |
Net Cash Flow | 1,494 | 256 | 74 | 393 | 636 | 21 |
Free Cash Flow | 1,347 | 1,148 | 749 | 842 | 1,042 | 236 |
Free Cash Flow Growth | 51.35% | 53.27% | -11.04% | -19.19% | 341.52% | -63.01% |
Free Cash Flow Margin | 7.78% | 6.65% | 4.53% | 5.31% | 6.98% | 1.49% |
Free Cash Flow Per Share | 1.16 | 0.99 | 0.66 | 0.75 | 0.94 | 0.21 |
Levered Free Cash Flow | 2,220 | 2,032 | 2,623 | 3,298 | 2,900 | 2,307 |
Unlevered Free Cash Flow | 2,758 | 2,604 | 3,249 | 3,941 | 3,481 | 2,863 |
Cash Interest Paid | 950 | 950 | 1,004 | 1,078 | 948 | 913 |
Cash Income Tax Paid | 558 | 558 | 471 | 298 | 543 | 495 |
Change in Working Capital | -1,111 | -1,366 | -435 | -72 | 1,355 | -1,701 |